CIK: 0001801265 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $944,370 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GHC | GRAHAM HLDGS CO | 235,271 | $205,137 | 21.7% | $517.36 | +67.5% | COM CL B | 384637104 |
| SOLV | SOLVENTUM CORP | 2,827,672 | $186,796 | 19.8% | $60.63 | +15.5% | COM SHS | 83444M101 |
| WLY | WILEY JOHN & SONS INC | 2,096,793 | $91,651 | 9.7% | $35.71 | +31.3% | CL A | 968223206 |
| TBPH | THERAVANCE BIOPHARMA INC | 9,511,150 | $89,500 | 9.5% | $10.06 | -9.6% | COM | G8807B106 |
| ACHC | ACADIA HEALTHCARE COMPANY INC | 1,925,327 | $76,339 | 8.1% | $45.11 | 0.0% | COM | 00404A109 |
| — | ENDEAVOR GROUP HLDGS INC | 2,397,658 | $75,023 | 7.9% | $30.46 | — | CL A COM | 29260Y109 |
| MAGN | MAGNERA CORP | 3,406,293 | $61,892 | 6.6% | $20.46 | 0.0% | COM SHS | 55939A107 |
| STGW | STAGWELL INC | 7,147,662 | $47,032 | 5.0% | $6.94 | +2.7% | COM CL A | 85256A109 |
| — | INDIVIOR PLC | 3,673,426 | $45,661 | 4.8% | $10.29 | — | ORD | G4766E116 |
| NNI | NELNET INC | 290,213 | $30,998 | 3.3% | $87.89 | +25.8% | CL A | 64031N108 |
| INVX | INNOVEX INTERNATIONAL INC | 1,686,476 | $23,560 | 2.5% | $15.64 | -4.1% | COM | 457651107 |
| FSP | FRANKLIN STR PPTYS CORP | 2,733,418 | $5,002 | 0.5% | $2.37 | — | COM | 35471R106 |
| OVID | OVID THERAPEUTICS INC | 3,722,627 | $3,476 | 0.4% | $2.26 | -50.4% | COM | 690469101 |
| — | 2SEVENTY BIO INC | 579,895 | $1,705 | 0.2% | $4.33 | — | COMMON STOCK | 901384107 |
| SN | SHARKNINJA INC | 6,152 | $599 | 0.1% | $36.57 | +179.1% | COM SHS | G8068L108 |